ICRA Reports Full Utilization of Dr. Agarwal’s Health Care IPO Proceeds
Dr. Agarwals Health Care Ltd · Others (Uncategorized) · 06 Nov 2026, 1:26 am
ICRA Reports Full Utilization of Dr. Agarwal’s Health Care IPO Proceeds ICRA confirmed that Dr. Agarwal’s Health Care Limited fully utilized its gross IPO fresh issue proceeds of INR 300.00 crore with zero material deviations as of 30th Sep'26. Total offer-related expenses decreased to INR 12.650 crore from the estimated INR 27.354 crore, allowing the company to reallocate savings and revise General Corporate Purpose allocations upward to INR 92.350 crore. Along with INR 195.00 crore deployed for debt repayment, cumulative utilization reached 100%, leaving no unutilized funds remaining.
Original exchange filing (PDF)
More announcements from Dr. Agarwals Health Care Ltd
- Execution of Media Agreement by the Company with GoodEdge Advisory Private Limited. · 17 Nov 2026
- Transcript of the Discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter and half year ended September 30, 2026, at the analyst call .... · 11 Nov 2026
- Link for the Audio recording of the Analyst / Earnings Conference call held on the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and half year .... · 06 Nov 2026
- Corrigendum to the Outcome of Board Meeting held on November 05, 2026, is submitted · 06 Nov 2026
- Corrigendum to the Outcome of Board Meeting held on November 05, 2026, is submitted · 06 Nov 2026
- Presentation on the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2026 is attached. · 05 Nov 2026
- Consolidated and Standalone Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026, is attached · 05 Nov 2026
- Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter and Half Year Ended September 30, 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 · 05 Nov 2026
